PL439107A1 - Podstawione pochodne 1,1´-bifenylu w połączeniu z aminokwasami i dipeptydami do stosowania w immunoterapii nowotworów - Google Patents

Podstawione pochodne 1,1´-bifenylu w połączeniu z aminokwasami i dipeptydami do stosowania w immunoterapii nowotworów

Info

Publication number
PL439107A1
PL439107A1 PL439107A PL43910721A PL439107A1 PL 439107 A1 PL439107 A1 PL 439107A1 PL 439107 A PL439107 A PL 439107A PL 43910721 A PL43910721 A PL 43910721A PL 439107 A1 PL439107 A1 PL 439107A1
Authority
PL
Poland
Prior art keywords
dipeptides
combination
amino acids
cancer immunotherapy
substituted
Prior art date
Application number
PL439107A
Other languages
English (en)
Inventor
Ganna Gudz
Jan Barczyński
Przemysław Bielski
Michał Mikitiuk
Urszula Błaszkiewicz
Aleksandra Hec
Tomasz SITAR
Tadeusz Holak
Original Assignee
Recepton Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recepton Spółka Z Ograniczoną Odpowiedzialnością filed Critical Recepton Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL439107A priority Critical patent/PL439107A1/pl
Priority to EP22195637.8A priority patent/EP4159720A1/en
Publication of PL439107A1 publication Critical patent/PL439107A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Przedmiotem zgłoszenia są nowe pochodne 1,1'-bifenylu w połączeniu z aminokwasami i dipeptydami jako małocząsteczkowe inhibitory celujące w punkt kontroli odpowiedzi immunologicznej PD-1/PD-L1 mogące znaleźć zastosowanie w farmacji, zwłaszcza w immunoterapii nowotworów.
PL439107A 2021-09-30 2021-09-30 Podstawione pochodne 1,1´-bifenylu w połączeniu z aminokwasami i dipeptydami do stosowania w immunoterapii nowotworów PL439107A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL439107A PL439107A1 (pl) 2021-09-30 2021-09-30 Podstawione pochodne 1,1´-bifenylu w połączeniu z aminokwasami i dipeptydami do stosowania w immunoterapii nowotworów
EP22195637.8A EP4159720A1 (en) 2021-09-30 2022-09-14 Nonsymmetric substituted 1,1'-biphenyl derivatives and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL439107A PL439107A1 (pl) 2021-09-30 2021-09-30 Podstawione pochodne 1,1´-bifenylu w połączeniu z aminokwasami i dipeptydami do stosowania w immunoterapii nowotworów

Publications (1)

Publication Number Publication Date
PL439107A1 true PL439107A1 (pl) 2023-04-03

Family

ID=85783992

Family Applications (1)

Application Number Title Priority Date Filing Date
PL439107A PL439107A1 (pl) 2021-09-30 2021-09-30 Podstawione pochodne 1,1´-bifenylu w połączeniu z aminokwasami i dipeptydami do stosowania w immunoterapii nowotworów

Country Status (1)

Country Link
PL (1) PL439107A1 (pl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL447202A1 (pl) * 2023-12-21 2025-06-23 Uniwersytet Jagielloński Związek będący inhibitorem oddziaływania PD-L1/PD-1, kompozycja farmaceutyczna zawierająca inhibitor, oraz zastosowanie inhibitora
PL449370A1 (pl) * 2024-07-26 2026-02-02 Uniwersytet Jagielloński Nowe pochodne N-terfenylopikolinamidu oraz ich zastosowanie

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL447202A1 (pl) * 2023-12-21 2025-06-23 Uniwersytet Jagielloński Związek będący inhibitorem oddziaływania PD-L1/PD-1, kompozycja farmaceutyczna zawierająca inhibitor, oraz zastosowanie inhibitora
PL449370A1 (pl) * 2024-07-26 2026-02-02 Uniwersytet Jagielloński Nowe pochodne N-terfenylopikolinamidu oraz ich zastosowanie

Similar Documents

Publication Publication Date Title
SA522431915B1 (ar) Prmt5 مثبطات mta تعاونية مع
MX2021003554A (es) Proteinas de union a dll3 y metodos de uso.
PH12020500663A1 (en) Brm targeting compounds and associated methods of use
MX2022014548A (es) Inhibidores de molecula de muerte programada 1 (pd-1)/ligando de molecula de muerte programada 1 (pd-l1).
SA520420524B1 (ar) مشتقات تترا هيدرو [4،c-5] – إيميدازو pd-l1 بيريدين كمعدِّلات مناعية
MX2022005359A (es) Inhibidores de ras.
MX2022005357A (es) Inhibidores de ras.
CY1125017T1 (el) Ετεροκυκλυλαμινο-υποκατεστημενες τριαζολες ως ρυθμιστες της πρωτεϊνικης κινασης που σχετιζεται me rho
WO2020181232A8 (en) Heterocyclic compounds for medical treatment
BR112018068703A2 (pt) inibidores substituídos de menin-mll e métodos de uso
AU2018278311A1 (en) IRE1 small molecule inhibitors
EP4285906A3 (en) Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof
MX383614B (es) Proteinas de union triespecificas y metodos de uso.
BR112019010265A2 (pt) anticorpos anti_cd137 inovadores e usos dos mesmos
BR112022004972A2 (pt) Anticorpos, ácidos nucleicos isolados, células hospedeiras isoladas, métodos de produção de um anticorpo, de produção de um anticorpo biespecífico e de tratamento de um indivíduo, anticorpos biespecíficos, composição farmacêutica, anticorpo, anticorpo biespecífico ou composição farmacêutica, combinação de um anticorpo, uso do anticorpo, uso de uma combinação do anticorpo e métodos para reduzir a inflamação e para melhorar a descamação e/ou de erupção cutânea e combinação para uso
CY1126067T1 (el) Συντηγμενες πυρρολινες που δρουν σαν ειδικοι για ουβικιτινη αναστολεις πρωτεασης 30 (usp30)
PE20181805A1 (es) Composiciones y anticuerpos anti-tim-3
EA201892007A1 (ru) 3-дезоксипроизводное и фармацевтические композиции на его основе
MY198289A (en) Pharmaceutical Composition for use in a Method of Removing Immune Suppression in a Tumor Microenvironment or Stimulating an Immune System Against Cancer Cells
BR112012008624A2 (pt) inibidores de tirosina quinase de bruton
CL2008002478A1 (es) Compuestos derivados de n-fenil-5-(4 haloalcoxi)fenil) pirimidin-2-amino, inhibidores de c-kit y pdgfr; composicion farmaceutica; y su uso en el tratmiento de asma, dermatitis atopica, hipertension pulmonar o arterial, fibrosis renal, pulmonar o cardiaca, entre otras.
PL439107A1 (pl) Podstawione pochodne 1,1´-bifenylu w połączeniu z aminokwasami i dipeptydami do stosowania w immunoterapii nowotworów
CN110382500A (zh) 用于ido和tdo双重抑制剂的脲类化合物
ZA202005325B (en) Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
UY38352A (es) Inhibidores de integrina alfavbeta6